# Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)

> **NCT01388244** · NA · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 35000 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **OTHER:** Screening
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT01388244
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 35000 (ACTUAL)
- **Last updated:** 2023-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388244, "Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01388244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*